Csf1R Inhibited Microglia is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Colony-stimulating factor 1 receptor (CSF1R) inhibition represents a promising therapeutic strategy for modulating microglial function in neurodegenerative diseases. Understanding the effects of CSF1R inhibition on microglia is crucial for developing targeted treatments. [1]
This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer's disease, Parkinson's disease, and related conditions. [2]
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:0000129 | microglial cell |
| Database | ID | Name | Confidence | [3]
|----------|----|------|------------| [4]
| Cell Ontology | CL:0000129 | microglial cell | Medium |
CSF1R signaling regulates:
CSF1R inhibition approaches for AD:
In PD models, CSF1R inhibition shows:
Drugs in development:
The study of Csf1R Inhibited Microglia has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.